...
首页> 外文期刊>The Lancet >Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial.
【24h】

Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial.

机译:住院中风患者的常规口服营养补充剂(FOOD):一项多中心随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Undernutrition is common in hospital patients with stroke, can develop or worsen in hospital, and is associated with poor outcomes. We aimed to establish whether routine oral nutritional supplements improve outcome after stroke. METHODS: The FOOD trials are a family of three pragmatic, multicentre, randomised controlled trials. We measured the outcomes of stroke patients who could swallow and who were randomly allocated normal hospital diet or normal hospital diet plus oral nutritional supplements until hospital discharge. The primary outcome was death or poor outcome (modified Rankin scale [MRS] grade 3-5), 6 months after enrollment, measured unaware of treatment allocation. Analysis was by intention to treat. FINDINGS: Between Nov 1, 1996, and July 31, 2003, 4023 patients were enrolled by 125 hospitals in 15 countries. Only 314 (8%) patients were judged to be undernourished at baseline. Vital status and MRS at the end of the trial were known for 4012 and 4004 patients, respectively. Supplemented diet was associated with an absolute reduction in risk of death of 0.7% (95% CI -1.4 to 2.7) and an increased risk of death or poor outcome of 0.7% (-2.3 to 3.8). INTERPRETATION: We could not confirm the anticipated 4% absolute benefit for death or poor outcome from routine oral nutritional supplements for mainly well nourished stroke patients in hospital. Our results would be compatible with a 1% or 2% absolute benefit or harm from oral supplements. These results do not support a policy of routine oral supplementation after stroke.
机译:背景:营养不良在中风患者中很常见,在医院中可能发展或恶化,并与不良预后相关。我们旨在确定常规口服营养补充剂是否可以改善卒中后的预后。方法:食品试验是一组三项实用,多中心,随机对照试验。我们测量了可吞咽并随机分配正常医院饮食或正常医院饮食加口服营养补充剂直至出院的中风患者的结局。入组后6个月,主要预后为死亡或预后不良(改良Rankin量表[MRS] 3-5级),测量时未意识到治疗分配。分析是按意向进行的。结果:在1996年11月1日至2003年7月31日期间,有15个国家的125家医院纳入了4023例患者。在基线时,仅314名(8%)患者被认为营养不良。试验结束时分别有4012和4004例患者的生命状况和MRS已知。补充饮食可使死亡风险绝对降低0.7%(95%CI -1.4至2.7)和死亡风险或不良结局增加0.7%(-2.3至3.8)。解释:我们不能确定对于主要营养良好的中风患者而言,常规口服营养补充剂对死亡或不良结局的预期4%绝对获益。我们的结果将与口服补品带来的1%或2%的绝对收益或损害相吻合。这些结果不支持中风后常规口服补充剂的政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号